Bellevue Life Sciences Ac... (BLAC)
11.40
0.06 (0.53%)
At close: Jan 03, 2025, 9:00 PM
Company Description
Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities.
The company intends to acquire companies in the healthcare industry.
Bellevue Life Sciences Acquisition Corp. was founded in 2020 and is based in Bellevue, Washington.
Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.
Bellevue Life Sciences Acquisition Corp.
| Country | United States |
| IPO Date | Mar 21, 2023 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | Kuk Hyoun Hwang |
Contact Details
Address: 10900 NE 4th Street Bellevue, Washington United States | |
| Website | n/a |
Stock Details
| Ticker Symbol | BLAC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001840425 |
| CUSIP Number | 079174108 |
| ISIN Number | US0791741087 |
| Employer ID | 84-5052822 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Kuk Hyoun Hwang | Chief Executive Officer & Executive Chairman |
| David Jin Yoo | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 27, 2024 | S-4/A | [Amend] Filing |
| Dec 23, 2024 | 425 | Filing |
| Dec 23, 2024 | 8-K | Current Report |
| Nov 14, 2024 | 10-Q | Quarterly Report |
| Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Nov 12, 2024 | 8-K | Current Report |
| Nov 08, 2024 | S-4/A | [Amend] Filing |
| Oct 28, 2024 | ARS | Filing |
| Oct 28, 2024 | DEF 14A | Filing |
| Oct 28, 2024 | 425 | Filing |